From the Apex Heart Institute, Ahmedabad, India (T.M.P., S.C.S., Y.Y.S., R.C.R., P.O.T.).
The Wright Center for Graduate Medical Education, Scranton, PA (G.A.P., S.B.P.).
Circ Cardiovasc Interv. 2020 May;13(5):e008888. doi: 10.1161/CIRCINTERVENTIONS.119.008888. Epub 2020 May 14.
Robotic percutaneous coronary intervention (R-PCI) has been shown to benefit the operator but has not shown any significant benefit to the patient. We sought to compare a large cohort of R-PCI to traditional percutaneous coronary intervention (PCI) procedures performed at a tertiary care center in the same time frame.
A total of 996 consecutive patients referred for PCI between December 2017 and March 2019 were studied, of which 310 (31.1%) patients were selected to undergo R-PCI and 686 (68.9%) patients underwent traditional PCI. The coprimary study outcome measures were air kerma, dose-area product, fluoroscopy time, volume of contrast, and total procedural time. Caliper propensity-matching technique was used (caliper, 0.05) to match each R-PCI patient to the nearest traditional PCI patient without replacement.
Air kerma (mGy; median [interquartile range]; ; 884 [537-1398] versus 1110 [699-1498]; =0.002) and dose-area product (cGycm; 4734 [2695-7746] versus 5746 [3751-7833]; =0.003) were significantly lower in the R-PCI group. There was no difference in fluoroscopy time (minutes; 5.51 [3.53-8.31] versus 5.48 [3.31-9.37]; =0.936) and contrast volume (mL; 130 [103-170] versus 140 [100-180]; =0.905). Total procedural time (minutes) was significantly higher in the R-PCI group (27 [21-40] versus 37 [27-50]; <0.0005).
R-PCI is associated with a significant decrease in radiation exposure to the patient with no increase in fluoroscopy time, as well as contrast utilization, and a minor increase in procedure duration compared with traditional PCI.
机器人经皮冠状动脉介入治疗(R-PCI)已被证明对操作者有益,但对患者没有任何显著益处。我们旨在比较同一时期在三级护理中心进行的大型 R-PCI 队列和传统经皮冠状动脉介入治疗(PCI)手术。
研究纳入了 2017 年 12 月至 2019 年 3 月间因 PCI 而就诊的 996 例连续患者,其中 310 例(31.1%)患者选择接受 R-PCI,686 例(68.9%)患者接受传统 PCI。主要研究终点是空气比释动能、剂量-面积乘积、透视时间、造影剂用量和总手术时间。采用卡尺倾向评分匹配技术(卡尺,0.05)对每个 R-PCI 患者进行无替换的最近传统 PCI 患者匹配。
R-PCI 组的空气比释动能(mGy;中位数[四分位间距];;884 [537-1398] 与 1110 [699-1498];=0.002)和剂量-面积乘积(cGycm;4734 [2695-7746] 与 5746 [3751-7833];=0.003)明显更低。透视时间(分钟;5.51 [3.53-8.31] 与 5.48 [3.31-9.37];=0.936)和造影剂用量(mL;130 [103-170] 与 140 [100-180];=0.905)无差异。R-PCI 组的总手术时间(分钟)明显更长(27 [21-40] 与 37 [27-50];<0.0005)。
与传统 PCI 相比,R-PCI 可显著降低患者的辐射暴露,而透视时间、造影剂使用和手术时间仅有轻微增加。